An appraisal of therapeutic implications of Unmada Gaja Kesari Rasa in Various Neuropsychiatric disorders
DOI:
https://doi.org/10.70066/jahm.v11i3.753Keywords:
Unmada, Unmada Gaja Kesari Rasa, Unmadgaja Kesar Rasa, Antipsychotic, Antidepressant, Anticonvulsant, AyurvedaAbstract
Unmada Gaja Kesari Rasa is a traditional herbo-mineral compound cited in the lexicon of the 15th century AD. As the name suggests, it is commonly prescribed in Unmada. The classics also recommend its use in Apasmara and other psychiatric conditions, such as Jwara (fever) and Bhootonmada (exogenous Unmada). The standard antipsychotics pose adverse effects that may substantially affect the quality of life of psychiatric patients. Therefore, there is a need to explore the novel drug in the management of psychotic diseases. In Ayurveda, psychiatric disorders are referred to as Unmada, and the line of management of Unmada has proven to be beneficial in various psychiatric conditions such as MDD, Schizophrenia, etc. Unmada Gaja Kesari Rasa is the first drug of choice in Unmada. Therefore, we planned to study the formulation, its variations in composition, dose, adjuvant, therapeutic utility, and method of preparation. As the formulation contains a potent toxic drug, we also studied its toxicity profile. Citations of relevant studies are enumerated.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Shrilata, JS Tripathi

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.